Compounds of formula (I) or pharmaceutically acceptable salts thereof, exhibit 5-HT
1A
agonism in addition to noradrenaline reuptake inhibition and optionally also 5-HT reuptake inhibition are useful for the treatment of obesity.
[EN] DIHYDROIMIDAZOTHIAZOLE DERIVATIVES<br/>[FR] DERIVES DE DIHYDRO-IMIDAZOTHIAZOLE
申请人:PROSIDION LTD
公开号:WO2006085118A2
公开(公告)日:2006-08-17
[EN] Compounds of formula (I): or pharmaceutically acceptable salts thereof, exhibit 5-HT1A agonism in addition to noradrenaline reuptake inhibition and optionally also 5-HT reuptake inhibition are useful for the treatment of obesity. [FR] L'invention concerne des composés de la formule (I), ou des sels pharmaceutiquement acceptables de ceux-ci, qui présentent un agonisme 5-HT1A, outre l'inhibition de la recapture de la noradrénaline et éventuellement l'inhibition de la recapture de 5-HT, et qui sont utilisés dans le traitement de l'obésité.